Great Point Partners’s Erasca ERAS Stock Holding History

Great Point Partners’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,538,461	Closed	-$6.63M	–	46
2022 Q4	$6.63M	Buy	+1,538,461	New	+$10.4M	1.3%	28

Other funds holding ERAS

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Great Point Partners's ERAS Position: Q1 2023 in Review

Great Point Partners sold out of Erasca (ERAS) in Q1 2023, closing a stake of 1,538,461 shares — an estimated $6.63M sold.

Great Point Partners first reported a position in ERAS in Q4 2022 and held it in 1 quarter. The position peaked at $6.63M in Q4 2022. 117 funds tracked by Wall St. Rank hold ERAS as of Q1 2023.

Great Point Partners reported no remaining Erasca position as of Q1 2023 after selling out during the quarter.
Great Point Partners sold 1,538,461 Erasca shares in Q1 2023, an estimated $6.63M.
Great Point Partners first reported a position in Erasca in Q4 2022 and held it in 1 quarter.
Great Point Partners's Erasca position peaked at $6.63M in Q4 2022.
117 funds tracked by Wall St. Rank held Erasca as of Q1 2023.

Based on Great Point Partners's 13F filing for Q1 2023, filed 15 May 2023.